Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

Bibliographic Details
Main Authors:	Catalina Abad, Bhavaani Jayaram, Laurine Becquet, Yuqi Wang, M. Sue O’Dorisio, James A. Waschek, Yossan-Var Tan
Format:	Article
Language:	English
Published:	BMC 2017-08-01
Series:	Journal of Neuroinflammation
Online Access:	http://link.springer.com/article/10.1186/s12974-017-0927-1

Similar Items

Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
by: Yossan-Var Tan, et al.
Published: (2013-01-01)

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
by: Laurine Becquet, et al.
Published: (2019-03-01)

VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.
by: Catalina Abad, et al.
Published: (2012-01-01)

Correction: VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
by: Catalina Abad, et al.
Published: (2013-01-01)

Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular Models
by: Yukio Ago, et al.
Published: (2021-07-01)

Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
by: Burak Ulkumen, et al.
Published: (2022-07-01)

The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota
by: Aaron C. Ericsson, et al.
Published: (2022-01-01)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
by: Satoshi Asano, et al.
Published: (2022-09-01)

Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (<em>Ondatra zibethicus</em>)
by: Zeqi Tang, et al.
Published: (2022-05-01)

Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function
by: Xavier Peyrassol, et al.
Published: (2018-04-01)

PAC<sub>1</sub>, VPAC<sub>1</sub>, and VPAC<sub>2</sub> Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
by: Zoe Tasma, et al.
Published: (2022-11-01)

2113 Non-contrast enhanced renal MRA with PC VIPR
by: Busse Reed F, et al.
Published: (2008-10-01)

Visualizing and quantifying cerebrospinal venous flow using PC-VIPR
by: Schrauben Eric M, et al.
Published: (2012-02-01)

Anatomical and functional imaging of congenital heart disease with phase contrast VIPR
by: Reeder Scott B, et al.
Published: (2009-01-01)

Understanding VPAC receptor family peptide binding and selectivity
by: Sarah J. Piper, et al.
Published: (2022-11-01)

Identification of VIPR2 rare and common variants in the Chinese Han population with schizophrenia
by: Jiajun Yin, et al.
Published: (2023-04-01)

VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice.
by: Ivan Ivic, et al.
Published: (2019-01-01)

PACAP regulates VPAC1 expression, inflammatory processes and lipid homeostasis in M1- and M2-macrophages
by: Roman Witzel, et al.
Published: (2023-10-01)

Research Note: Association of VIPR-1 gene polymorphism with growth traits in meat type Japanese quail (Coturnix Japonica)
by: Junyan Bai, et al.
Published: (2023-08-01)

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
by: Alain Couvineau, et al.
Published: (2019-10-01)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
by: Matthew Cummings, et al.
Published: (2018-01-01)

lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
by: Xia-Hui Lin, et al.
Published: (2022-08-01)

Tamoxifen-inducible cardiac-specific Cre transgenic mouse using VIPR2 intron
by: Hyun Jung Chin, et al.
Published: (2020-09-01)

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients
by: Deborah Theiler, et al.
Published: (2021-12-01)

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.
by: Iria V Seoane, et al.
Published: (2016-01-01)

Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
by: Rajendra B. Nerli, et al.
Published: (2023-04-01)

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance
by: Rosa P. Gomariz, et al.
Published: (2019-10-01)

VPAC: Variational projection for accurate clustering of single-cell transcriptomic data
by: Shengquan Chen, et al.
Published: (2019-05-01)

PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
by: Jens Hannibal, et al.
Published: (2017-01-01)

Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.
by: Bo Tang, et al.
Published: (2013-01-01)

The VIP/VPAC1R Pathway Regulates Energy and Glucose Homeostasis by Modulating GLP-1, Glucagon, Leptin and PYY Levels in Mice
by: Daniel Sanford, et al.
Published: (2022-03-01)

Genetic variants of INHA/PstI and VIPR1/HhaI and their relationship with reproductive traits in Ac chicken (Gallus gallus domesticus Brisson)
by: Le Thanh Phuong, et al.
Published: (2023-05-01)

Localization of Vasoactive Intestinal Polypeptide Receptor 1 (VPAC1) in Hypothalamic Neuroendocrine Oxytocin Neurons; A Potential Role in Circadian Prolactin Secretion
by: Ida Stangerup, et al.
Published: (2020-10-01)

Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies.
by: Ingrid eLanger
Published: (2012-10-01)

Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors
by: Rajendra B Nerli, et al.
Published: (2021-01-01)

VPAC Receptor Subtypes Tune Purinergic Neuron-to-Glia Communication in the Murine Submucosal Plexus
by: Pieter Vanden Berghe, et al.
Published: (2017-04-01)

Genetic susceptibility to refractive error: association of vasoactive intestinal peptide receptor 2 (VIPR2) with high myopia in Chinese.
by: Wai Chi Yiu, et al.
Published: (2013-01-01)

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures
by: Amalia Lamana, et al.
Published: (2022-08-01)

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
by: Xintong Hou, et al.
Published: (2022-09-01)

Endogenous VIP VPAC<sub>1</sub> Receptor Activation Modulates Hippocampal Theta Burst Induced LTP: Transduction Pathways and GABAergic Mechanisms
by: Ana Caulino-Rocha, et al.
Published: (2022-04-01)